BR9710569A - Derivados de piridazino ¬4,5-B¾-quinolina 5-Äxido prepara-Æo delles e uso dos mesmos como antagonistas de glicina - Google Patents

Derivados de piridazino ¬4,5-B¾-quinolina 5-Äxido prepara-Æo delles e uso dos mesmos como antagonistas de glicina

Info

Publication number
BR9710569A
BR9710569A BR9710569A BR9710569A BR9710569A BR 9710569 A BR9710569 A BR 9710569A BR 9710569 A BR9710569 A BR 9710569A BR 9710569 A BR9710569 A BR 9710569A BR 9710569 A BR9710569 A BR 9710569A
Authority
BR
Brazil
Prior art keywords
äxide
quinoline
preparation
pyridazine derivatives
glycine antagonists
Prior art date
Application number
BR9710569A
Other languages
English (en)
Inventor
Wojciech Danysz
Markus Gold
Ivars Kalvinsh
Christopher Graham Rap Parsons
Irene Piskunova Eugene Rozhkov
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of BR9710569A publication Critical patent/BR9710569A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR9710569A 1996-07-25 1997-07-25 Derivados de piridazino ¬4,5-B¾-quinolina 5-Äxido prepara-Æo delles e uso dos mesmos como antagonistas de glicina BR9710569A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/686,346 US5776935A (en) 1996-07-25 1996-07-25 Pyrido-phtalazin diones and their use against neurological disorders associated with excitotoxicity and malfunctioning of glutamatergic neurotransmission
PCT/EP1997/004057 WO1998004556A1 (en) 1996-07-25 1997-07-25 Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists

Publications (1)

Publication Number Publication Date
BR9710569A true BR9710569A (pt) 1999-08-17

Family

ID=24755940

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710569A BR9710569A (pt) 1996-07-25 1997-07-25 Derivados de piridazino ¬4,5-B¾-quinolina 5-Äxido prepara-Æo delles e uso dos mesmos como antagonistas de glicina

Country Status (31)

Country Link
US (1) US5776935A (pt)
EP (1) EP0931081B1 (pt)
JP (1) JP3595342B2 (pt)
KR (1) KR100598206B1 (pt)
CN (1) CN1093860C (pt)
AR (1) AR004158A1 (pt)
AT (1) ATE224894T1 (pt)
AU (1) AU719993B2 (pt)
BR (1) BR9710569A (pt)
CA (1) CA2261923C (pt)
CZ (1) CZ289293B6 (pt)
DE (1) DE69715893T2 (pt)
DK (1) DK0931081T3 (pt)
EA (1) EA001711B1 (pt)
ES (1) ES2180041T3 (pt)
FI (1) FI112946B (pt)
GE (1) GEP20022801B (pt)
HK (1) HK1020193A1 (pt)
HU (1) HU223780B1 (pt)
IL (1) IL128225A (pt)
LT (1) LT4591B (pt)
LV (1) LV12260B (pt)
NO (1) NO310820B1 (pt)
PL (1) PL189572B1 (pt)
PT (1) PT931081E (pt)
SI (1) SI9720048B (pt)
SK (1) SK283536B6 (pt)
TW (1) TW402605B (pt)
UA (1) UA63911C2 (pt)
WO (1) WO1998004556A1 (pt)
ZA (1) ZA976612B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176435A1 (en) * 2002-12-17 2003-09-18 Brown Dean Gordon Compounds and methods for the treatment of pain
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
CA2457011C (en) * 2001-08-20 2012-04-24 Maiken Nedergaard Treatment of glial tumors with glutamate antagonists
EP1298581A1 (fr) * 2001-09-27 2003-04-02 C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa Procédé et dispositif pour calculer les valeurs des neurones d'un réseau neuronal
US7105185B2 (en) 2001-10-03 2006-09-12 Herbalscience, Llc Kavalactone profile
US20050069596A1 (en) * 2001-10-03 2005-03-31 Gow Robert T. Compositions and methods comprising kava and anti-anxiety compounds
US7029707B2 (en) * 2001-10-03 2006-04-18 Herbalscience, Llc Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
US7291352B2 (en) 2001-10-03 2007-11-06 Herbalscience Llc Methods and compositions for oral delivery of Areca and mate' or theobromine
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
US7001620B2 (en) 2001-10-03 2006-02-21 Herbal Science, Llc Kavalactone product
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
CN1917892A (zh) * 2003-10-24 2007-02-21 草本制药科学有限责任公司 包含冬青的方法和组合物
US7294353B2 (en) * 2003-10-24 2007-11-13 Herbalscience, Llc Methods and compositions comprising ilex
CA2604078C (en) * 2005-04-08 2013-07-23 Abbott Laboratories Enteric pharmaceutical formulations of choline salt of fenofibric acid
NZ584098A (en) * 2007-09-20 2012-05-25 Cortex Pharma Inc 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
EP2264035A1 (en) * 2009-06-04 2010-12-22 Merz Pharma GmbH & Co. KGaA Glycine B antagonists
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
JP7305560B2 (ja) 2017-06-12 2023-07-10 グリテック， エルエルシー Ｎｍｄａアンタゴニスト及びｄ２／５ｈｔ２ａ又は選択的５ｈｔ２ａアンタゴニストによるうつ病の治療
USD895157S1 (en) 2018-03-06 2020-09-01 IsoTruss Indsutries LLC Longitudinal beam
CN109912503B (zh) * 2019-04-01 2022-04-08 江南大学 一种2,3-二酰基喹啉类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9208511D0 (en) * 1991-05-09 1992-06-03 Ici Plc Compounds
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore

Also Published As

Publication number Publication date
AU4296997A (en) 1998-02-20
EP0931081B1 (en) 2002-09-25
IL128225A (en) 2005-09-25
PT931081E (pt) 2003-02-28
HUP9903104A3 (en) 2000-04-28
CA2261923A1 (en) 1998-02-05
LV12260A (lv) 1999-04-20
WO1998004556A1 (en) 1998-02-05
FI112946B (fi) 2004-02-13
DE69715893D1 (de) 2002-10-31
DK0931081T3 (da) 2003-01-27
CN1228778A (zh) 1999-09-15
CA2261923C (en) 2006-01-24
HUP9903104A2 (hu) 2000-03-28
EA199900161A1 (ru) 1999-10-28
IL128225A0 (en) 1999-11-30
FI990134A (fi) 1999-03-24
ES2180041T3 (es) 2003-02-01
NO310820B1 (no) 2001-09-03
CZ2019997A3 (cs) 1999-09-15
JP2000515872A (ja) 2000-11-28
SK10399A3 (en) 2000-01-18
LT4591B (lt) 1999-12-27
CZ289293B6 (cs) 2001-12-12
US5776935A (en) 1998-07-07
TW402605B (en) 2000-08-21
CN1093860C (zh) 2002-11-06
AR004158A1 (es) 1998-11-04
PL331323A1 (en) 1999-07-05
ZA976612B (en) 1998-02-10
NO990306D0 (no) 1999-01-22
UA63911C2 (uk) 2004-02-16
LV12260B (en) 1999-08-20
SK283536B6 (sk) 2003-09-11
KR20000029568A (ko) 2000-05-25
ATE224894T1 (de) 2002-10-15
NO990306L (no) 1999-03-15
EP0931081A1 (en) 1999-07-28
DE69715893T2 (de) 2003-01-30
AU719993B2 (en) 2000-05-18
KR100598206B1 (ko) 2006-07-07
JP3595342B2 (ja) 2004-12-02
PL189572B1 (pl) 2005-08-31
HU223780B1 (hu) 2005-01-28
LT99007A (en) 1999-07-26
FI990134A0 (fi) 1999-01-25
SI9720048A (sl) 1999-12-31
SI9720048B (sl) 2002-02-28
EA001711B1 (ru) 2001-06-25
GEP20022801B (en) 2002-09-25
HK1020193A1 (en) 2000-03-31

Similar Documents

Publication Publication Date Title
BR9710569A (pt) Derivados de piridazino ¬4,5-B¾-quinolina 5-Äxido prepara-Æo delles e uso dos mesmos como antagonistas de glicina
BR9708400A (pt) Composição sua preparação e uso
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
BR9706385A (pt) Antagonistas de receptores de vitronectina preparação e uso dos mesmos
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
BR9708457A (pt) Uso de N-(fosfonometil) glicina e seus derivados
BR9706129A (pt) 3-Hidroxiprina-2-Carboxamidoésteres preparação deles e uso dos mesmos como substâncias farmacêuticas
BR9707501A (pt) Composto composição farmacêutica e uso do composto
HK1030939A1 (en) Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
EE04431B1 (et) Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena
BR9711724A (pt) Derivado de 3,4,5,6,7,8-hexaidro-pirido (4',3':4,5)tieno-(2,3-d) pirimidina 3-substitu¡da e uso do mesmo
BR9707812A (pt) Composto composto farmacêutica e uso do composto
HUP9901630A3 (en) Indole-2,3-dione-3-oxime derivatives as antagonists of excitatory amino acids, preparation and use thereof
BR9609694A (pt) Derivados de peperazina e uso dos mesmos como antagonistas a 5-ht1a
BR9709906A (pt) Derivados de benzamida substituídos e o uso dos mesmos como anticonvulsivantes
FR2766823B1 (fr) Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
BR9702084A (pt) Antagonista de peptídeo de mitogénese e motogénese celulares e o uso terapeutico dos mesmos
BR9911178B1 (pt) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO COM BASE NOS ART. 10( VIII ) DA LPI 9.279, DE 14 DE MAIO DE 1996

B12B Appeal against refusal [chapter 12.2 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time